Horiguchi Hironori, Sato Tatsuhiko, Kumada Hiroaki, Yamamoto Tetsuya, Sakae Takeji
Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan
Nuclear Science and Engineering Directorate, Japan Atomic Energy Agency, 2-4, Shirakata-shirane, Tokai, Ibaraki 319-1195, Japan.
J Radiat Res. 2015 Mar;56(2):382-90. doi: 10.1093/jrr/rru109. Epub 2014 Nov 26.
The absorbed doses deposited by boron neutron capture therapy (BNCT) can be categorized into four components: α and (7)Li particles from the (10)B(n, α)(7)Li reaction, 0.54-MeV protons from the (14)N(n, p)(14)C reaction, the recoiled protons from the (1)H(n, n) (1)H reaction, and photons from the neutron beam and (1)H(n, γ)(2)H reaction. For evaluating the irradiation effect in tumors and the surrounding normal tissues in BNCT, it is of great importance to estimate the relative biological effectiveness (RBE) for each dose component in the same framework. We have, therefore, established a new method for estimating the RBE of all BNCT dose components on the basis of the microdosimetric kinetic model. This method employs the probability density of lineal energy, y, in a subcellular structure as the index for expressing RBE, which can be calculated using the microdosimetric function implemented in the particle transport simulation code (PHITS). The accuracy of this method was tested by comparing the calculated RBE values with corresponding measured data in a water phantom irradiated with an epithermal neutron beam. The calculation technique developed in this study will be useful for biological dose estimation in treatment planning for BNCT.
硼中子俘获疗法(BNCT)沉积的吸收剂量可分为四个部分:硼-10(¹⁰B)(n,α)锂-7(⁷Li)反应产生的α粒子和锂-7粒子、氮-14(¹⁴N)(n,p)碳-14(¹⁴C)反应产生的0.54兆电子伏特质子、氢-1(¹H)(n,n)氢-1反应产生的反冲质子,以及中子束和氢-1(n,γ)氢-2(²H)反应产生的光子。为了评估BNCT中肿瘤及周围正常组织的辐照效果,在同一框架下估算各剂量成分的相对生物效能(RBE)非常重要。因此,我们基于微剂量动力学模型建立了一种估算所有BNCT剂量成分RBE的新方法。该方法采用亚细胞结构中线能量y的概率密度作为表示RBE的指标,可使用粒子输运模拟代码(PHITS)中实现的微剂量函数进行计算。通过将计算得到的RBE值与用超热中子束辐照水模体时相应的测量数据进行比较,测试了该方法的准确性。本研究中开发的计算技术将有助于BNCT治疗计划中的生物剂量估算。